Ken Griffin Enzo Biochem Inc Put Options Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$1.3 - $1.87 $520 - $748
-400 Reduced 3.2%
12,100 $16,000
Q2 2023

Aug 14, 2023
SELL
$1.84 - $2.66 $49,128 - $71,022
-26,700 Reduced 68.11%
12,500 $23,000
Q1 2023

May 15, 2023
SELL
$1.0 - $2.51 $21,800 - $54,717
-21,800 Reduced 35.74%
39,200 $95,000
Q4 2022

Feb 14, 2023
BUY
$1.16 - $2.42 $33,988 - $70,906
29,300 Added 92.43%
61,000 $87,000
Q3 2022

Nov 14, 2022
BUY
$2.1 - $2.73 $66,570 - $86,541
31,700 New
31,700 $71,000

Others Institutions Holding ENZ

# of Institutions
46
Shares Held
15.3M
Call Options Held
34K
Put Options Held
0
View Full List

About ENZO BIOCHEM INC

ENZ Quotes by TradingView
  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $56.5M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email